Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer

被引:22
作者
Mcheik, Soha [1 ]
Aptecar, Leticia [1 ,3 ]
Coopman, Peter [1 ,2 ]
D'Hondt, Veronique [1 ]
Freiss, Gilles [1 ]
机构
[1] Univ Montpellier, Inst Rech Cancerol Montpellier, Inst Reg Canc Montpellier, INSERM,U1194,IRCM, F-34298 Montpellier, France
[2] CNRS Ctr Natl Rech Sci, 1919 Route Mende, F-34293 Montpellier, France
[3] CHU St Eloi, Serv Oncol Med, 80 Ave Augustin Fliche, Montpellier, France
关键词
PTPN13; cell signaling; cancer; tumor suppressor; oncogene; NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; FAS-ASSOCIATED PHOSPHATASE-1; BREAST-CANCER; MEDIATED APOPTOSIS; PDZ DOMAIN; MUTATIONAL ANALYSIS; PROGNOSTIC MARKER; MOLECULAR-CLONING; FAP-1; EXPRESSION;
D O I
10.3390/biom10121659
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this review article, we present the current knowledge on PTPN13, a class I non-receptor protein tyrosine phosphatase identified in 1994. We focus particularly on its role in cancer, where PTPN13 acts as an oncogenic protein and also a tumor suppressor. To try to understand these apparent contradictory functions, we discuss PTPN13 implication in the FAS and oncogenic tyrosine kinase signaling pathways and in the associated biological activities, as well as its post-transcriptional and epigenetic regulation. Then, we describe PTPN13 clinical significance as a prognostic marker in different cancer types and its impact on anti-cancer treatment sensitivity. Finally, we present future research axes following recent findings on its role in cell junction regulation that implicate PTPN13 in cell death and cell migration, two major hallmarks of tumor formation and progression.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 147 条
[1]   PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis [J].
Abaan, OD ;
Levenson, A ;
Khan, O ;
Furth, PA ;
Üren, A ;
Toretsky, JA .
ONCOGENE, 2005, 24 (16) :2715-2722
[2]   Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1 [J].
Abaan, Ogan D. ;
Hendriks, Wiljan ;
Ueren, Aykut ;
Toretsky, Jeffrey A. ;
Erkizan, Hayriye V. .
EXPERIMENTAL CELL RESEARCH, 2013, 319 (01) :1-11
[3]  
BANVILLE D, 1994, J BIOL CHEM, V269, P22320
[4]   Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde? [J].
Baudry, Michel .
CURRENT NEUROPHARMACOLOGY, 2019, 17 (09) :823-829
[5]   Genetic disorders of programmed cell death in the immune system [J].
Bidere, Nicolas ;
Su, Helen C. ;
Lenardo, Michael J. .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :321-352
[6]   Substrate-trapping techniques in the identification of cellular PTP targets [J].
Blanchetot, C ;
Chagnon, M ;
Dubé, N ;
Hallé, A ;
Tremblay, ML .
METHODS, 2005, 35 (01) :44-53
[7]   Membrane targeting of protein tyrosine phosphatase PTPL1 through its FERM domain via binding to phosphatidylinositol 4,5-biphosphate [J].
Bompard, G ;
Martin, M ;
Roy, C ;
Vignon, F ;
Freiss, G .
JOURNAL OF CELL SCIENCE, 2003, 116 (12) :2519-2530
[8]   Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells [J].
Bompard, G ;
Puech, C ;
Prébois, C ;
Vignon, F ;
Freiss, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :47861-47869
[9]   Investigation of the Insulin-Like Growth Factor-1 Signaling Pathway in Localized Ewing Sarcoma A Report From the Children's Oncology Group [J].
Borinstein, Scott C. ;
Barkauskas, Donald A. ;
Krailo, Mark ;
Scher, Daniel ;
Scher, Lauren ;
Schlottmann, Silke ;
Kallakury, Bhaskar ;
Dickman, Paul S. ;
Pawel, Bruce R. ;
West, Daniel C. ;
Womer, Richard B. ;
Toretsky, Jeffrey A. .
CANCER, 2011, 117 (21) :4966-4976
[10]   Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells [J].
Bowler, Elizabeth ;
Porazinski, Sean ;
Uzor, Simon ;
Thibault, Philippe ;
Durand, Mathieu ;
Lapointe, Elvy ;
Rouschop, Kasper M. A. ;
Hancock, John ;
Wilson, Ian ;
Ladomery, Michael .
BMC CANCER, 2018, 18